We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+0.73%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$24.1B
AUM Growth
+$1.97B
Cap. Flow
+$2.05B
Cap. Flow %
8.49%
Top 10 Hldgs %
10.49%
Holding
3,709
New
1,118
Increased
953
Reduced
622
Closed
747

Sector Composition

Rank Sector Weight
1 Healthcare 20.28%
2 Financials 16.56%
3 Technology 13.74%
4 Consumer Discretionary 11.01%
5 Communication Services 4.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVO
1851
Novo Nordisk
NVO
$225B
$1.27M 0.01%
+26,444
New +$1.28M
TVTX icon
1852
Travere Therapeutics
TVTX
$5.2B
$1.27M 0.01%
+52,307
New +$961K
BZFDW icon
1853
CALL
BuzzFeed Inc Warrant
BZFDW
$905K
$1.27M 0.01%
+127,901
New +$162K
DFS
1854
DELISTED
Discover Financial Services
DFS
$1.27M 0.01%
+10,308
New +$1.29M
PRDS
1855
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$1.27M 0.01%
127,202
+7,202
+6% +$71.5K
BTWNW
1856
CALL
DELISTED
Bridgetown Holdings Limited Warrants
BTWNW
$1.26M 0.01%
128,992
-7,508
-6% -$10.9K
CORZ
1857
DELISTED
Core Scientific, Inc. Common Stock
CORZ
$1.26M 0.01%
124,980
JNCE
1858
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$1.26M 0.01%
169,686
-81,792
-33% -$507K
KRUS icon
1859
Kura Sushi USA
KRUS
$583M
$1.26M 0.01%
+28,814
New +$1.33M
OLMA icon
1860
Olema Pharmaceuticals
OLMA
$1.01B
$1.26M 0.01%
+45,578
New +$1.23M
INMB icon
1861
INmune Bio
INMB
$45.5M
$1.26M 0.01%
+64,650
New +$1.25M
ECH icon
1862
iShares MSCI Chile ETF
ECH
$1B
$1.25M 0.01%
48,283
-61,582
-56% -$1.68M
SPIR.WS
1863
CALL
DELISTED
Spire Global, Inc. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per whole share
SPIR.WS
$1.25M 0.01%
+100,000
New +$153K
MA icon
1864
CALL
Mastercard
MA
$497B
$1.25M 0.01%
+3,600
New +$1.31M
AMTX icon
1865
Aemetis
AMTX
$104M
$1.25M 0.01%
68,289
+39,435
+137% +$436K
AVTR icon
1866
Avantor
AVTR
$8.48B
$1.25M 0.01%
+30,516
New +$1.19M
BNNRU
1867
DELISTED
Banner Acquisition Corp. Units
BNNRU
$1.25M 0.01%
+125,416
New +$1.25M
EDRY icon
1868
EuroDry
EDRY
$70.4M
$1.25M 0.01%
+40,094
New +$1.08M
HGAS
1869
DELISTED
Global Gas Corporation Class A Common Stock
HGAS
$1.25M 0.01%
+125,769
New +$1.23M
TRI icon
1870
Thomson Reuters
TRI
$45.1B
$1.24M 0.01%
+10,678
New +$1.24M
WMT icon
1871
CALL
Walmart Inc
WMT
$900B
$1.24M 0.01%
26,700
+19,200
+256% +$925K
FRONW
1872
CALL
DELISTED
Frontier Acquisition Corp. Warrant
FRONW
$1.24M 0.01%
127,645
APRN
1873
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
$1.24M 0.01%
+14,025
New +$738K
UNFI icon
1874
United Natural Foods
UNFI
$3.07B
$1.24M 0.01%
+25,502
New +$903K
ACTG icon
1875
Acacia Research
ACTG
$447M
$1.23M 0.01%
+181,764
New +$1.11M

Similar funds

Marshall Wace's Q3 2021 Portfolio in Review

As of Q3 2021, Marshall Wace held 3,709 positions worth $24.1B, up 8.9% from $22.1B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Marshall Wace deployed $2.05B of net new capital in Q3 2021, opening 1,118 new positions and adding to 953 existing holdings. Its largest new stake was SkinHealth Systems: 4,113,430 shares worth $107M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Biogen, an estimated $210M trimmed.

  • Marshall Wace's largest Q3 2021 buy was SkinHealth Systems: 4,113,430 shares worth $107M.
  • Marshall Wace added most to Uber in Q3 2021, an estimated $127M increase.
  • Marshall Wace's biggest Q3 2021 reduction was Biogen, cutting an estimated $210M.
  • Marshall Wace fully exited Vipshop in Q3 2021, selling an estimated $58.7M.
  • Marshall Wace's ten largest holdings make up 10% of its $24.1B portfolio in Q3 2021.
  • Marshall Wace opened 1,118 new positions and closed 747 in Q3 2021.
  • Marshall Wace's portfolio value rose 8.9% quarter-over-quarter to $24.1B.

Based on Marshall Wace's 13F filing for Q3 2021, filed 15 Nov 2021.